Clinical Trial Update: Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis [Phase 2]

View source ↗

Summary

Phase 2 study of evinacumab in adults with severe hypertriglyceridemia for prevention of recurrent acute pancreatitis has been terminated; results were posted o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia
• Pancreatitis

Drugs mentioned

• Evinacumab (evinacumab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Hypertriglyceridemia | Phase 2 | Status: TERMINATED | Results posted: 2024-05-22